2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
701
Breast Neoplasms
630
Neoplasms
584
Leukemia, Myeloid, Acute
481
Colorectal Neoplasms
458
Multiple Myeloma
445
Melanoma
426
Prostatic Neoplasms
383
Neoplasm Metastasis
374
Pancreatic Neoplasms
364
Recurrence
351
Lymphoma
340
Ovarian Neoplasms
325
Lung Neoplasms
298
Lymphoma, Non-Hodgkin
295
Leukemia
287
Glioblastoma
276
Precursor Cell Lymphoblastic Leukemia-Lymphoma
249
Stomach Neoplasms
246
Leukemia, Lymphocytic, Chronic, B-Cell
235
Carcinoma, Hepatocellular
232
Squamous Cell Carcinoma of Head and Neck
220
Lymphoma, Large B-Cell, Diffuse
217
Myelodysplastic Syndromes
212
Carcinoma, Renal Cell
211
Lymphoma, Follicular
183
Head and Neck Neoplasms
172
Brain Neoplasms
169
Lymphoma, Mantle-Cell
167
Triple Negative Breast Neoplasms
166
Interventions
abiraterone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
×
Clear all
NCT01780220
2022-05-19
CARLHA
UNICANCER
Phase 1/2
Completed
47 enrolled